AwardTape · Defense awards · Medical · Diagnostics and lab supplies · HT941024P0004
HT941024P0004: $228K purchase order to Quidelortho Sales Company, LLC
Quidelortho Sales Company, LLC holds a purchase order from Defense Health Agency with $228K obligated since Oct 2023, against a ceiling of $475K. Latest action Mar 5, 2026.
Ortho diagnostics reagents
| PIID | HT941024P0004 |
|---|---|
| Type | purchase order |
| Company | Quidelortho Sales Company, LLC |
| Agency | Defense Health Agency |
| Contracting office | DEFENSE HEALTH AGENCY HCD WEST |
| Category | Medical · Diagnostics and lab supplies |
| PSC | 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS |
| NAICS | 325413 IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING |
| Obligated since Oct 2023 | $228K |
| Total obligated (lifetime) | $228K |
| Ceiling (base and all options) | $475K |
| Base date | Oct 17, 2023 |
| Latest action | Mar 5, 2026 |
| End date | Sep 30, 2028 |
| Actions since Oct 2023 | 9 |
| Pricing | Firm fixed price |
| Competition | Not competed under simplified acquisition |
| Place of performance | CA |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial